362 related articles for article (PubMed ID: 31690612)
1. Endotype-driven prediction of acute exacerbations in chronic obstructive pulmonary disease (EndAECOPD): protocol for a prospective cohort study.
Xiao W; Du LY; Mao B; Miao TW; Fu JJ
BMJ Open; 2019 Nov; 9(11):e034592. PubMed ID: 31690612
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Endotype-associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis.
Wang Z; Locantore N; Haldar K; Ramsheh MY; Beech AS; Ma W; Brown JR; Tal-Singer R; Barer MR; Bafadhel M; Donaldson GC; Wedzicha JA; Singh D; Wilkinson TMA; Miller BE; Brightling CE
Am J Respir Crit Care Med; 2021 Jun; 203(12):1488-1502. PubMed ID: 33332995
[No Abstract] [Full Text] [Related]
3. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.
Mayhew D; Devos N; Lambert C; Brown JR; Clarke SC; Kim VL; Magid-Slav M; Miller BE; Ostridge KK; Patel R; Sathe G; Simola DF; Staples KJ; Sung R; Tal-Singer R; Tuck AC; Van Horn S; Weynants V; Williams NP; Devaster JM; Wilkinson TMA;
Thorax; 2018 May; 73(5):422-430. PubMed ID: 29386298
[TBL] [Abstract][Full Text] [Related]
4. The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Huang YJ; Boushey HA
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S176-80. PubMed ID: 26595736
[TBL] [Abstract][Full Text] [Related]
5. Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease.
Su L; Qiao Y; Luo J; Huang R; Xiao Y
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291689
[TBL] [Abstract][Full Text] [Related]
6. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients.
Tangedal S; Nielsen R; Aanerud M; Persson LJ; Wiker HG; Bakke PS; Hiemstra PS; Eagan TM
PLoS One; 2019; 14(9):e0222449. PubMed ID: 31527888
[TBL] [Abstract][Full Text] [Related]
7. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
Fu JJ; McDonald VM; Baines KJ; Gibson PG
Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
[TBL] [Abstract][Full Text] [Related]
8. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
Huang YJ; Sethi S; Murphy T; Nariya S; Boushey HA; Lynch SV
J Clin Microbiol; 2014 Aug; 52(8):2813-23. PubMed ID: 24850358
[TBL] [Abstract][Full Text] [Related]
9. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
[TBL] [Abstract][Full Text] [Related]
10. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
Baines KJ; Fu JJ; McDonald VM; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
[TBL] [Abstract][Full Text] [Related]
11. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
12. Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD.
Dicker AJ; Crichton ML; Cassidy AJ; Brady G; Hapca A; Tavendale R; Einarsson GG; Furrie E; Elborn JS; Schembri S; Marshall SE; Palmer CNA; Chalmers JD
Thorax; 2018 Jun; 73(6):510-518. PubMed ID: 29101284
[TBL] [Abstract][Full Text] [Related]
13. Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.
Pragman AA; Knutson KA; Gould TJ; Isaacson RE; Reilly CS; Wendt CH
Respir Res; 2019 Jun; 20(1):114. PubMed ID: 31174538
[TBL] [Abstract][Full Text] [Related]
14. Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state.
Yang CY; Li SW; Chin CY; Hsu CW; Lee CC; Yeh YM; Wu KA
J Transl Med; 2021 Mar; 19(1):121. PubMed ID: 33757530
[TBL] [Abstract][Full Text] [Related]
15. Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study.
Bourne S; Cohet C; Kim V; Barton A; Tuck A; Aris E; Mesia-Vela S; Devaster JM; Ballou WR; Clarke SC; Wilkinson T
BMJ Open; 2014 Mar; 4(3):e004546. PubMed ID: 24607562
[TBL] [Abstract][Full Text] [Related]
16. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
[TBL] [Abstract][Full Text] [Related]
17. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
19. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
20. Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort.
Bouquet J; Tabor DE; Silver JS; Nair V; Tovchigrechko A; Griffin MP; Esser MT; Sellman BR; Jin H
Respir Res; 2020 Mar; 21(1):77. PubMed ID: 32228581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
